Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community
Abstract Background Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death. Few persons who initiate MOUD are retained on treatment, thus it is critical to identif...
Main Authors: | Breanne E. Biondi, Brent Vander Wyk, Esther F. Schlossberg, Albert Shaw, Sandra A. Springer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-03-01
|
Series: | Addiction Science & Clinical Practice |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13722-022-00299-1 |
Similar Items
-
Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder
by: Breanne E. Biondi, et al.
Published: (2021-03-01) -
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
by: Joseph Sadek, et al.
Published: (2022-07-01) -
Methadone Maintenance Therapy (MMT) and Alternatives in Opioid Use Disorder: Reviewing the latest advancements, outcomes, and challenges in substitutional therapy for opioid addiction - literature review
by: Karolina Koszyczarek, et al.
Published: (2024-02-01) -
Implementation of a regional quality improvement collaborative to improve care of people living with opioid use disorder in a Canadian setting
by: Laura Beamish, et al.
Published: (2019-09-01) -
Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
by: Michael Soyka
Published: (2021-11-01)